|
Pre-Conference Workshops
AM Half-Day
Workshops:
PM Half-Day
workshops:
|
|
A. |
Monday, January 26 /
8:00a-12:00p
Tools & Processes to Jump
Start your Open Innovation Efforts - A Framework for
Success |
 |
INSTRUCTOR
Gene
Slowinski
Director,
Strategic Alliance Research
Rutgers University
Managing Partner
Alliance Management Group
|
|
| |
Open Innovation is
transforming the nature of product development. To
compete effectively in today’s business environment,
firms are using strategic alliances to link their
resources with those of other world-class
organizations. They start by focusing on replacing
the "not invented here" syndrome with the "invented
anywhere approach". Unfortunately, many
Co-Development alliances fail. Managers from the
start must deal with the complexities of
cooperatively developing intellectual assets,
linking decision-making structures and building
cross-corporate innovation networks. Dr. Slowinski’s
25 years of work on over 300 CoDev alliances led him
to identify key best practices for a novice or
veteran of open innovation. He will present a set of
simple, but powerful management tools and metrics.
Many firms use these tools to increase the value of
both their individual alliances and their alliance
portfolios.
What you will
learn:
-
Starting out -
Organizational structures that can help or
hinder open innovation
-
How to use the 25%
rule as a financial model to share risks and
rewards in open innovation relationships
-
How to start
implementing "open innovation" by using the
"Want, Find, Get, and Manage Model"
-
How to accelerate
product development performance via
CoDevelopment
-
Lessons from
failures; common pitfalls and how to avoid them
-
Effective
strategies to resolve cultural differences in
alliances from the get go
- Proven tools,
metrics, and management techniques for
successfully implementing "Open Innovation"
relationships such as the Alliance Framework®
and the Alliance Implementation Programs
Gene Slowinski
is the Director of
Strategic Alliance Research at the Graduate School
of Management, Rutgers University, an Executive
Affiliate with PRTM and Managing Partner of the
Alliance Management Group, a consulting firm devoted
to the formation and management of strategic
alliances, mergers and acquisitions. Prior to
forming the Alliance Management Group, he held
management positions at AT&T Bell Laboratories, and
Novartis Corporation. In addition to a Ph.D. in
Management, Gene holds an MBA, and a Masters Degree
in the sciences. He is a member of Los Alamos
National Laboratory’s Technology Commercialization
Advisory Board. For the last 25 years Dr. Slowinski
has consulted and conducted research on the
formation and management of strategic alliances,
joint ventures, mergers, and acquisitions. His
clients include GlaxoSmithKline, Merck, Lucent
Technologies, Motorola, Johnson & Johnson, Ethicon,
ExxonMobil, General Mills, Eastman Chemical, Kraft,
Becton Dickinson, and many other Fortune 500 firms.
With Matt Sagal, he co-authored the book The
Strongest Link. His new book, Reinventing Corporate
Growth is the leading book on growing the
corporation.
|
|
|
B. |
Monday, January 26 /
8:00a-12:00p
Closing the Deal:
Effective Strategies & Structures |
|
 |
INSTRUCTOR
Karin A.
Gregory
Managing Partner
Furman Gregory LLC |
|
|
| |
Open
innovation requires a combination of business and
negotiation skills to achieve a good result for your
organization. This workshop discusses the types of deals
that are done from both the small company and large
company perspectives, such as the use of equity as part
of the deal structure. We will explore deal structures
for different types of deals involving technology and
health care products and joint venture models. All
presenters have years of experience inside small and
large enterprises and have intimate knowledge of deal
structures from both sides. This workshop will examine
proven methods to overcome the challenges and avoid the
pitfalls to make the deal meet the objectives of both
organizations in a timely and effective manner. The
presenting team will discuss cases involving a
healthcare and technology company involving two or more
deal features.
By
attending this workshop, you will come away with:
-
Basic structures of
different types of deals, such as R&D partnerships,
equity features of deals, product and distribution
oriented deals and joint ventures
-
Key deal terms and
definitions to get it right
-
Knowledge of common
deal terms and how to use them effectively
-
Effective strategies
to avoid the pitfalls that might make the deal
unsuccessful
-
Insights into the
models that work for large and small company
partnerships
-
Case study examples
that will drive home key points to consider when
structuring a deal with a small or larger enterprise
|
Guest Presenters: |
 |
D'Anne Hurd
Vice President Business Development at Gateway
Park;
Vice President and General Counsel
Worcester Polytechnic Institute (WPI) |
 |
Dr.
Val R. Livada
Founder
Weybridge Partners and Senior Lecturer, Sloan
School of Business, MIT |
Karin A. Gregory’s career spans over
25 years in the healthcare field, as a basic
scientist, healthcare administrator, lawyer and
venture capitalist. She began her career in health
care in 1980 at MIT in basic science research and
then at Dana Farber Cancer Institute where she ran a
successful start up outpatient department devoted to
breast cancer. In 1988, she shifted to the law,
having just completed her health services masters
studies, focused in Technology and Policy at the
Franklin Pierce Law Center. Thereafter, Ms. Gregory
provided legal services to health care organizations
in private practice as well as in the public sector.
In early 1998, she joined the Massachusetts
Technology Development Corporation (MTDC), an early
stage state-sponsored venture capital firm located
in Boston as an investment professional. In
mid-2002, Ms. Gregory left MTDC and co-founded Dover
Medical Ventures, L.P., an early stage medical
device venture capital fund and eMedicus, Inc., a
commercial IRB for the review and monitoring of
clinical research studies being conducted by
pharmaceutical and device companies in the field of
oncology. Currently, Ms. Gregory teamed up with
Donald Furman to form Furman Gregory to represent
early stage healthcare and technology companies and
to offer business consultation to these companies
and other entities, including private equity funds.
|
|
|
C. |
Monday, January 26 /
1:30p-5:00p
Managing IP in an Open
Innovation Environment |
 |
INSTRUCTOR
Paul
Germeraad
President
Intellectual Assets, Inc. |
|
| |
Companies today are managing their IP and Open
Innovation initiatives with varying degrees of
success. When these two processes are combined the
results can be anything from great to catastrophe.
This workshop is focused on improving the quality of
both IP management and open innovation initiatives
with a particular focus on the overlap and synergy
that can be obtained when done thoughtfully. These
merged capabilities are becoming evermore important
to incorporate into a company’s open innovation
process because shortened product development cycles
and regional IP differences offer competitors
greater opportunity to take advantage of strategic
mistakes. In this workshop Dr. Paul Germeraad will
draw on his Fortune 500 and Dot.com corporate
experiences, as well as his research in management
consulting to provide company examples that will
provide attendees with detailed insight on how to
proceed and what pitfalls to avoid.
Participants will learn:
-
How managing IP
and conducting Open Innovation are inter-related
-
How the six steps
of finding and integrating Open Innovation
technology with the help of IP databases
increases the quality of projects and decreases
time to market
-
How development
projects based on market share, growth rate and
IP density give appropriate project selection
criteria for one company but incent an Open
Innovation partner to behave differently
-
How to decipher IP
patterns for appropriate Open Innovation
decisions
-
How a dozen
learning’s about doing Open Innovation well
apply to IP management
-
How the geographic
distribution of IP tells you where to develop
and first commercialize new products
Paul Germeraad is
President of Intellectual Assets, Inc., a
professional advisory services firm specializing in
integrated business, R&D, and IP processes. Dr.
Germeraad was previously Chief Operating Officer for
Aurigin Systems, Inc., a software start-up company
focused on the development of intellectual asset
management products for the Competitive
Intelligence, Licensing and R&D communities. Prior
to joining Aurigin in 1998, Paul worked for three
Fortune 500 companies. He served as Vice President,
Corporate Research for Avery Dennison. Before
joining Avery Dennison, Paul was director of James
River Corporation's Flexible Packaging Technical
Center and held a variety of R&D and management
positions at Raychem Corporation.
Paul is past Chairman
of the Industrial Research Institute, an
organization of Chief Technology Officers whose
organizations account for over 70% of all US R&D
spending. Paul is past Trustee and VP Education for
the Licensing Executives Society (LES USA-Canada),
is an instructor for the LES Professional
Development Series and served as Chair of the LESI
Education Committee.
Paul is a graduate of
the University of California, San Diego, with a B.A.
in Chemistry. In addition, Paul holds a Ph.D. in
Chemistry from the University of California, Irvine
and an LL.B degree from La Salle University.
|
|
|
D. |
Monday, January 26 /
1:30p-5:00p
Defining and Implementing
an Effective Open Innovation Metrics Portfolio |
|
 |
INSTRUCTOR
Cheryl
Perkins
President & Founder
Innovationedge™
LLC |
 |
INSTRUCTOR
Jeff Lindsay
Director, Solution
Development
Innovationedge™
LLC |
|
| |
Open
Innovation is not measured by many companies and the few
corporations that do track their progress are often
misguided on which elements to consider. Cheryl Perkins,
Founder and President of Innovationedge, members of the
Innovationedge team and other innovation leaders from
corporations such as Kimberly-Clark Corporation and
Colgate will be discussing which metrics are the most
valuable to track along your open innovation journey.
The group will provide a wide variety of case studies on
how to improve your measurement practices and, as a
result, boost return on innovation spending and promote
an Open Innovation culture. You’ll gain valuable
perspectives on how companies can take their performance
measurement activities to the next level and uncover the
key ingredients of their success.
You will learn:
-
How to define a
portfolio of metrics that align with your open
innovation strategy and model(s) for your company,
including both behavioral and results oriented
metrics.
-
How to measure the
entire Open Innovation effort, including the inputs,
processes and desire outcomes.
-
How important it is to
keep it simple yet follow a disciplined approach.
-
How to evolve your
company to deliver higher value.
-
What tools and
approaches work best.
-
How to ensure metrics
are meaningful and actionable.
|
Guest Presenters: |
 |
Amy Achter
Director of Corporate
Intellectual Asset Management
Kimberly-Clark Corporation |
 |
Mary Beth Robles
VP External Innovation
Colgate-Palmolive |
Cheryl Perkins is a
thought leader in innovation and a creative catalyst
in brand-building initiatives that contribute to
rewarding consumer experiences and improved business
performance. She was identified as one of the Top 25
Champions of Innovation by BusinessWeek magazine in
June 2006. As President of Innovationedge LLC, she
is leading companies across many industries build
sustainable innovation capabilities and define
sustainable growth opportunities. Her work involves
designing and implementing organizational
structures, processes,systems and tools that enable
open innovation and growth. These include but are
not limited to growth incubators for new business
development, design capabilities, strategic
alliances and partnerships, environmental
sustainability, safety and regulatory affairs,
disruptive technologies and product brokering, and
portfolio management. Cheryl has over 23 years
experience directing growth and innovation and most
recently served as the SVP and Chief Innovation
Officer for Kimberly-Clark Corporation.
Jeff Lindsay is
Director of Solution Development at Innovationedge
and is a registered U.S. Patent Agent and a leading
expert in Intellectual Asset law and strategy. Prior
to joining Innovationedge, Jeff was the Corporate
Strategist and Senior Research Fellow at Kimberly
Clark Corporation and was granted 101 US patent.
While at Kimberly Clark, Jeff developed and advanced
the concept of “Disruptive Intellectual Asset
Strategy,” where intellectual assets are used to
overcome normal barriers to disruptive innovation.
Jeff founded and chaired an Intellectual Asset group
dedicated to identifying and protecting “business
methods,” and guided Kimberly-Clark in pursuing an
aggressive publications strategy. He is currently
Chair of the Forest Bioproducts Division of the
American Instituteof Chemical Engineers and is also
a member of the Licensing Executive Society |
|
|
|
